for the Period Ended 31 May 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 May 2023
Directors
The directors shown below have held office during the whole of the period from
1 June 2022 to 31 May 2023
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2023 | 2022 | |
---|---|---|
| £ | £ |
Turnover: | | |
Gross profit(or loss): | | |
Administrative expenses: | ( | ( |
Operating profit(or loss): | | |
Profit(or loss) before tax: | | |
Profit(or loss) for the financial year: | | |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Current assets | |||
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 3 | ( | |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Total net assets (liabilities): | | | |
Members' funds | |||
Profit and loss account: | | | |
Total members' funds: | | |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 May 2023
Basis of measurement and preparation
for the Period Ended 31 May 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 31 May 2023
2022 | ||
---|---|---|
£ | ||
Accruals and deferred income | | |
Total | |
During the last financial year Oxytocin-Learning continued with a key area of work embarkedproviding culturally appropriate provision. This entailed partnership work with Black ThriveGlobal to offer culturally appropriate advocacy training. Oxytocin Learning also engaged inwork with Thrive London promoting citywide public mental health.
The stakeholders of Oxytocin-Learning are people who access the support that is provided. The stakeholders are engaged to find out what their needs are. As a result of this engagement the directors try to source funds to meet necessary needs.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
7 February 2024
And signed on behalf of the board by:
Name: Anthony Salla
Status: Director